Phase 1 Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with platinum-resistant, relapsed, high-grade ovarian cancer, primary peritoneal cancer, or fallopian tube cancer, who have had at least one previous treatment containing a platinum-based chemotherapy drug and whose cancer came back or got worse during or within 6 months of finishing that treatment
- People who have previously received bevacizumab (a targeted therapy) and/or a PARP inhibitor drug as part of their treatment, unless their doctor determined those treatments were not suitable for them
- People with a general health and activity level rated as 0 or 1 on a standard medical scale, meaning they are either fully active or have only minor restrictions on physically strenuous activity (confirm with trial site)
Who may not be able to join:
- People who have spinal cord compression, or who have a history of cancer spreading to the membranes surrounding the brain and spinal cord
- People who still have side effects rated moderate or higher from previous cancer treatments that have not yet resolved
- People who have a history of non-infectious lung inflammation (a condition affecting the lung tissue) that required steroid tablets, steroid injections, or extra oxygen, or where this type of lung condition cannot be ruled out by scans done at the start of the trial
- People who have had a serious, uncontrolled illness at any point in the 12 months before the screening stage of the trial
- People for whom the trial drug itraconazole would be medically unsuitable based on the drug's prescribing information or the treating doctor's assessment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1-877-240-9479
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Area under curve from time 0 to time 17 days (AUC0-17days); Maximum plasma drug concentration (Cmax)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.